ANIKA THERAPEUTICS INC (ANIK)

US0352551081 - Common Stock

25.54  +0.18 (+0.71%)

After market: 25.54 0 (0%)

Full profile views are only available for registered users, you can see which data is available below.

Examples of complete profiles are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional data.

ANIKA THERAPEUTICS INC

NASDAQ:ANIK (3/27/2024, 8:00:01 PM)

After market: 25.54 0 (0%)

25.54

+0.18 (+0.71%)

Chartmill TA Rating
Chartmill Setup Rating
Sector
GICS SectorHealth Care
GICS IndustryBiotechnology
Chartmill FA Rating
Valuation
Growth
Profitability
Health
Dividend
Overview
Earnings (Last)
Earnings (Next)
Ins Owners
Inst Owners
Market Cap373.91M
Shares
PEN/A
Fwd PEN/A
Dividend YieldN/A
Analysts
IPO
Stock Screener Links
Screen Image

Nasdaq Stock Screener

Find more stocks on Nasdaq

Screen Image

USA Stock Screener

Find more stocks on the USA

Screen Image

GICS Sector Stock Screener

Find competitors from the same sector on the USA

Screen Image

GICS Industry Stock Screener

Find competitors from the same industry on the USA

Screen Image

Technical Stock Screener

Find stocks with similar TA and Setup ratings on the USA

Screen Image

Fundamental Stock Screener

Find stocks with similar Fundamental rating on the USA

Screen Image

Best Technical Competitors Stock Screener

Find the competitors with the best technical ratings on the USA

Screen Image

Best Technical Setups Competitors Stock Screener

Find the competitors with the best technical and setup ratings on the USA

Screen Image

Best Fundamental Competitors Stock Screener

Find the competitors with the best fundamentals on the USA

Screen Image

Best Valuation Competitors Stock Screener

Find the competitors with the best valuation on the USA

Screen Image

Best Dividend Competitors Stock Screener

Find the competitors with the best dividend on the USA

Screen Image

Best Analyst Rating Competitors Stock Screener

Find the competitors with the best analyst ratings on the USA

ANIK Daily chart

Company Profile

Anika Therapeutics, Inc. is an orthopedic and regenerative medicines company, which develops, manufactures and commercializes therapeutic products for pain management, tissue regeneration, and wound healing. The company is headquartered in Bedford, Massachusetts and currently employs 345 full-time employees. The firm is engaged in creating and delivering advancements in early intervention orthopedic care, including osteoarthritis (OA) pain management, regenerative solutions, sports medicine and Arthrosurface joint solutions. The firm is focused on developing, manufacturing, and commercializing products based on its hyaluronic acid (HA) technology platform. The Company’s product line includes OA Pain Management, Joint Preservation and Restoration, and Non-Orthopedic. Its OA Pain Management product consists of Monovisc and Orthovisc, Cingal, and Hyvisc. Its Joint Preservation and Restoration consist of regenerative solutions, sports medicine, and Arthrosurface joint solutions. Monovisc and Orthovisc are single and multi-injection, HA-based Visco supplement products, Cingal, and Hyvis. Its Non-Orthopedic products consists of HA-based products that are marketed principally for non-orthopedic applications.

Company Info

ANIKA THERAPEUTICS INC

32 Wiggins Ave

Bedford MASSACHUSETTS 01730

P: 17814579000

CEO: Cheryl R. Blanchard

Employees: 345

Website: https://anika.com/

ANIK News

News Image15 days ago - Anika Therapeutics Inc.Anika Reports Fourth Quarter and Year-End 2023 Financial Results

Revenue growth and adjusted EBITDA1 exceeded expectations in the fourth quarter and full year OA Pain Management achieved record annual revenues of $102...

News Image20 days ago - Anika Therapeutics Inc.Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
News Image20 days ago - Anika Therapeutics Inc.Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

BEDFORD, Mass., March 08, 2024 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention...

News Imagea month ago - Anika Therapeutics Inc.Anika to Issue Fourth Quarter and Year-End 2023 Financial Results on Wednesday, March 13, 2024
News Imagea month ago - Anika Therapeutics Inc.Anika to Issue Fourth Quarter and Year-End 2023 Financial Results on Wednesday, March 13, 2024

BEDFORD, Mass., Feb. 27, 2024 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention...

News Imagea month ago - Anika Therapeutics Inc.Anika Highlights Its Recently Launched Integrity™ Implant System and RevoMotion™ Reverse Shoulder Arthroplasty System Along with Other Key Regenerative Products During the 2024 AAOS Annual Meeting

ANIK Twits

Here you can normally see the latest stock twits on ANIK, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.

Example Twits:

Twits example